Minor name changes.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: No new cohorts were added in this release.
Minor maintenance release.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: No new cohorts were added in this release.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 2 were added.
1316: Acquired Neutropenia or unspecified leukopenia (21Pe, 365Era)
1317: [P] Reyes syndrome
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 56 were added.
1217: [P] Platinum based chemotherapy regimens
1244: [P] Non Platinum chemotherapy regimen
1261: [P] Acute Typical Pneumonia
1262: [P] Asthma or Chronic obstructive pulmonary disease (COPD)
1263: [P] Chronic obstructive pulmonary disease (COPD) without asthma
1264: [P] Pneumonitis and lung infections
1265: [P] Pulmonary hypertension associated with lung diseases and or hypoxia (WHO Group 3)
1266: [P] Non-small cell lung cancer (NSCLC) for first time using ICD0
1267: [P] Lung cancer using ICD0
1268: [P] Lung Resection, adults, inpt stay, no ED, post op new Afib
1269: [P] Pulmonary fibrosis
1270: [P] History of Bladder cancer
1271: [P] Chronic obstructive pulmonary disease (COPD)
1272: [P] Chronic Interstitial lung disease (ILD)
1273: [P] Lung Nodule
1274: [P] Lung Nodule - solitary
1275: [P] Lung Nodule - multiple
1276: [P] Lung Mass (not acute, necrotic, atlectatic, abscess, fibrosis)
1277: [P] Lung Lesion (not acute, necrotic, atlectatic, abscess, fibrosis)
1278: [P] Non Small Cell Lung Cancer (Stage 3)
1279: [P] Non Small Cell Lung Cancer
1280: [P] Small Cell Lung Cancer
1281: [P] Primary Lung Cancer
1282: [P] Hoarseness
1283: [P] Bone Pain
1284: [P] Weight loss
1285: [P] Acute bronchitis
1286: [P] Non Small Cell Lung Cancer (Stage 3) without second diagnosis
1287: [P] Intestinal obstruction - colorectal specific
1288: [P] Intraabdominal abscess - narrow for colorectal cancer
1289: [P] Major Non Cardiac Surgery, adults
1290: [P] Abdominal Aortic Aneurysm repair, adults
1291: [P] Lower Extremity Bypass, adults
1292: [P] Carotid Endarterectomy, adults
1293: [P] Lung Resection, adults
1294: [P] Esophagectomy, adults
1295: [P] Pancreatectomy, adults
1296: [P] Colectomy, adults
1297: [P] Cystectomy, adults
1298: [P] Nephrectomy, adults
1299: [P] Coronary Artery Bypass Graft, adults
1300: [P] Cardiac Valve Surgery, adults
1301: [P] Acute Urinary tract infections UTI events
1303: [P] Acute Heart failure from legend
1304: [P] Major Non Cardiac Surgery, adults, post op new Afib
1305: [P] AAA repair, adults, post op new Afib
1306: [P] Lower Extremity Bypass, adults, post op new Afib
1307: [P] Carotid Endarterectomy, adults, post op new Afib
1308: [P] Lung Resection, adults, post op new Afib
1309: [P] Esophagectomy, adults, post op new Afib
1310: [P] Pancreatectomy, adults, post op new Afib
1311: [P] Colectomy, adults, post op new Afib
1312: [P] Cystectomy, adults, post op new Afib
1313: [P] Nephrectomy, adults, post op new Afib
1314: [P] Coronary Artery Bypass Graft, adults, post op new Afib
1315: [P] Cardiac Valve Surgery, adults, post op new Afib
Note: The following cohorts were accidentally deleted and we restored with new id.
| oldId | newId | Name |
|---|---|---|
| 19 | 1261 | [P] Acute Typical Pneumonia |
| 26 | 1262 | [P] Asthma or Chronic obstructive pulmonary disease (COPD) |
| 28 | 1263 | [P] Chronic obstructive pulmonary disease (COPD) without asthma |
| 329 | 1264 | [P] Pneumonitis and lung infections |
| 751 | 1265 | [P] Pulmonary hypertension associated with lung diseases and or hypoxia (WHO Group 3) |
| 786 | 1266 | [P] Non-small cell lung cancer (NSCLC) for first time using ICD0 |
| 787 | 1267 | [P] Lung cancer using ICD0 |
| 1096 | 1268 | [P] Lung Resection, adults, inpt stay, no ED, post op new Afib |
| 1117 | 1269 | [P] Pulmonary fibrosis |
| 1118 | 1270 | [P] History of Bladder cancer |
| 1119 | 1271 | [P] Chronic obstructive pulmonary disease (COPD) |
| 1120 | 1272 | [P] Chronic Interstitial lung disease (ILD) |
| 1128 | 1273 | [P] Lung Nodule |
| 1129 | 1274 | [P] Lung Nodule - solitary |
| 1130 | 1275 | [P] Lung Nodule - multiple |
| 1131 | 1276 | [P] Lung Mass (not acute, necrotic, atelectatic, abscess, fibrosis) |
| 1132 | 1277 | [P] Lung Lesion (not acute, necrotic, atelectatic, abscess, fibrosis) |
| 1133 | 1278 | [P] Non Small Cell Lung Cancer (Stage 3) |
| 1134 | 1279 | [P] Non Small Cell Lung Cancer |
| 1135 | 1280 | [P] Small Cell Lung Cancer |
| 1136 | 1281 | [P] Primary Lung Cancer |
| 1137 | 1282 | [P] Hoarseness |
| 1138 | 1283 | [P] Bone Pain |
| 1139 | 1284 | [P] Weight loss |
| 1218 | 1285 | [P] Acute bronchitis |
| 1232 | 1286 | [P] Non Small Cell Lung Cancer (Stage 3) without second diagnosis |
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 1 were added.
1232: [P] Non Small Cell Lung Cancer (Stage 3) without second diagnosis
Accepted Cohorts: No cohorts were accepted in this release.
Clinical Description template has been updated. Literature review instruction has been updated.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 8 were added.
1223: [P] Birdshot chorioretinitis
1224: [P] CMV Anterior Uveitis (sensitivity analysis)
1225: [P] VZV Anterior Uveitis (SUN)
1226: [P] VZV Anterior Uveitis (SUN) sensitive
1227: [P] HSV Anterior Uveitis (SUN)
1228: [P] HSV Anterior Uveitis (SUN) sensitive
1229: [P] Behcet Uveitis (SUN)
1231: [P] Sickle Cell Crisis
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 5 were added.
1218: [P] Acute bronchitis
1219: [P] Hyperlipidemia
1220: [P] Hypoparathyroidism
1221: [P] Osteoporosis
1222: [P] Viral hepatitis type A
Bug fix with getPhenotypeLog()
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 18 were added.
1117: [P] Pulmonary fibrosis
1118: [P] History of Bladder cancer
1119: [P] Chronic obstructive pulmonary disease (COPD)
1120: [P] Chronic Interstitial lung disease (ILD)
1128: [P] Lung Nodule
1129: [P] Lung Nodule - solitary
1130: [P] Lung Nodule - multiple
1131: [P] Lung Mass (not acute, necrotic, atlectatic, abscess, fibrosis)
1132: [P] Lung Lesion (not acute, necrotic, atlectatic, abscess, fibrosis)
1133: [P] Non Small Cell Lung Cancer as lung cancer without small cell
1134: [P] Lung Cancer (primary maliganancy)
1135: [P] Small Cell Lung Cancer
1136: [P] Non Small Cell Lung Cancer
1137: [P] Hoarseness
1138: [P] Bone Pain
1139: [P] Weight loss
1216: [P] Primary Lung Cancer, 2nd dx 365 d after, excl SCLC signs all d before 1y after
1217: [P] Primary Lung Cancer, excl SCLC signs all d before 1y after
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: No new cohorts were added in this release.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 64 were added. These Cohorts are part of the prediction study and contributed by Jenna Reps
1152: Deep Vein Thrombosis DVT 10
1153: Seizure 10
1154: Heart failure 10
1155: Non-hemorrhagic Stroke 10
1156: Hemorrhagic stroke 10
1157: peripheral vascular disease 10
1158: Aspirin 10
1159: Angina 10
1160: Atrial Fibrillation 10
1161: Major depressive disorder with NO occurrence of certain psychiatric disorder 10
1162: Coronary artery disease (CAD) 10
1163: Acute Kidney Injury 10
1164: Asthma 10
1165: Alcoholism 10
1166: Smoking 10
1167: sleep apnea 10
1168: skin ulcer 10
1169: Chronic hepatitis 10
1170: hyperlipidemia 10
1171: hypothyroidism 10
1172: Heart valve disorder 10
1173: Low back pain 10
1174: neuropathy 10
1175: Psychotic disorder 10
1176: Sepsis 10
1177: Acute Respiratory failure 10
1178: Gastroesophageal reflux disease 10
1179: obesity 10
1180: Inflammatory Bowel Disease 10
1181: STEROIDS 10
1182: Opioids 10
1183: ANTIEPILEPTICS 10
1184: Osteoarthritis 10
1185: Osteoporosis 10
1186: Urinary tract infectious 10
1187: acetaminophen exposure 10
1188: Anemia 10
1189: Anxiety 10
1190: HORMONAL CONTRACEPTIVES 10
1191: Chronic kidney disease or end stage renal disease 10
1192: Chronic obstructive pulmonary disease (COPD) 10
1193: Type 1 diabetes and no prior specific nonT1DM diabetes 10
1194: Type 2 Diabetes Mellitus with no type 1 or secondary DM 10
1195: Dyspnea 10
1196: Edema 10
1197: Acute gastrointestinal bleeding 10
1198: Hypertension 10
1199: Pneumonia 10
1200: Rheumatoid Arthritis 10
1201: Antibiotics Aminoglycosides 10
1202: Antibiotics Carbapenems 10
1203: Antibiotics Cephalosporins 10
1204: Antibiotics Fluoroquinolones 10
1205: Antibiotics Glycopeptides and lipoglycopeptides 10
1206: Antibiotics Macrolides 10
1207: Antibiotics Monobactams 10
1208: Antibiotics Oxazolidinones 10
1209: Antibiotics Penicillins 10
1210: Antibiotics Polypeptides 10
1211: Antibiotics Rifamycins 10
1212: Antibiotics Sulfonamides 10
1213: Antibiotics Streptogramins 10
1214: Antibiotics Tetracyclines 10
1215: Any cancer (excl. prostate cancer and benign cancer) 10
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 2 were added.
1150: Emergency room only or Emergency room and inpatient visits (0Pe, 0Era)
1151: [P] Autism
Following cohorts were hidden: 325 were added. To retrieve use PhenotypeLibrary::getPhenotypeLog(showHidden = TRUE).
2: [W] COVID-19 diagnosis or SARS-CoV-2 test (1pos)
15: [P][R] Exposure to viral disease
16: [W] Exposure to SARS-Cov 2 and coronavirus
17: [P][R] Exposure to SARS-CoV-2
18: [P][R] Multisystem inflammatory syndrome (MIS)
22: [W] SARS-CoV-2 testing
29: [W] Autoimmune condition (FP)
35: [W] Chronic kidney disease (FP)
39: [W] End stage renal disease (FP)
41: [W] Chronic kidney disease broad (FP)
42: [W] End stage renal disease broad (FP)
44: [P][R] COVID-19
45: [W] COVID-19 diagnosis with SARS-Cov-2 test (-3d to 3d)
46: [W] COVID-19 diagnosis and SARS-CoV-2 test (1pos) within 3d
47: [W] COVID-19 diagnosis and SARS-CoV-2 test (1pos) (0neg) within 3d
48: [W] COVID-19 diagnosis and SARS-CoV-2 test (0pos upto 3d, 1neg within 3d)
51: [W] SARS-CoV-2 test positive result
52: [W] SARS-CoV-2 test negative result
53: [W] SARS-CoV-2 test positive or negative result - keep persons with positive
57: [P][R] Bleeding
59: [W] COVID-19 diagnosis with no SARS-CoV-2 test
60: [W] SARS-CoV-2 test positive and negative result
62: [P][R] Seizure related finding
65: [W] Acute pancreatitis with inpatient admission
66: [W] Acute renal failure with inpatient admission
67: [W] Hepatic failure with inpatient admission
68: [W] Heart failure with inpatient admission
69: [W] Angioedema with inpatient admission
86: [W] SARS-CoV-2 test positive or negative result
87: [W] SARS-CoV-2 test
100: [P][R] Alzheimer's disease
189: [P][R] Right upper quadrant pain
190: [P][R] Swollen abdomen
226: [P][R] Drug reaction with eosinophilia and systemic symptoms
231: [P][R] Erythema multiforme
238: [P][R] Optic neuritis
241: [P][R] Urticaria
327: [P][R] Pharyngitis
330: [P][R] Abdominal bloating
339: [P][R] Low blood pressure
342: [P][R] Urinary incontinence
348: [P][R] Blood in urine
350: [P][R] Hemoptysis
352: [P][R] Inflamed tonsils
353: [P][R] Conjunctivitis
357: [P][R] Pulmonary edema
361: [P][R] Restless legs
363: [P][R] Joint stiffness
364: [P][R] Sleep disorder
368: [P][R] Sinusitis
369: [P][R] Allergic condition
374: [P][R] Drug dependence
376: [P][R] Bleeding skin
377: [P][R] Petechiae
378: [P][R] Purpuric disorder
380: [P][R] Jaundice
384: [P][R] Contact dermatitis
385: [P][R] Intertrigo
386: [P][R] Seborrheic dermatitis
387: [P][R] Photodermatitis
388: [P][R] Peripheral neuritis
396: [P][R] Osteoarthritis
397: [P][R] Hyperplasia of prostate
399: [P][R] Urolithiasis
400: [P][R] Malignant tumor of prostate
406: [P][R] Intellectual disability
407: [P][R] Hemorrhoids
415: [P][R] Erythema of skin
444: [P][R] Neck pain
445: [P][R] Hypoglycemia
446: [P][R] Eosinophilic esophagitis
447: [P][R] Esophagitis
448: [P][R] Dysphagia
449: [P][R] Nausea
450: [P][R] Constipation
451: [P][R] Myasthenia gravis
452: [P][R] Joint pain
453: [P][R] Osteoarthritis
454: [P][R] Dermatomyositis
455: [P][R] Fetal growth restriction
456: [P][R] Osteoporosis
457: [P][R] Rheumatoid arthritis
458: [P][R] Ulcerative colitis
459: [P][R] Urinary tract infectious disease
460: [P][R] Psoriasis with arthropathy
461: [P][R] Erythema multiforme
462: [P][R] Lichen planus
463: [P][R] Sepsis
464: [P][R] Myelofibrosis
465: [P][R] Thyroiditis
466: [P][R] Atopic dermatitis
467: [P][R] Systemic sclerosis
468: [P][R] Pityriasis rubra pilaris
469: [P][R] Jaundice
470: [P][R] Chronic lymphoid leukemia, disease
471: [P][R] Vitiligo
472: [P][R] Myelodysplastic syndrome (clinical)
473: [P][R] Acute transverse myelitis
474: [P][R] Pemphigoid
475: [P][R] Psoriasis
476: [P][R] Acute myeloid leukemia, disease
477: [P][R] Hypothyroidism
478: [P][R] Malignant melanoma of skin
479: [P][R] Chilblains
480: [P][R] Alopecia areata
481: [P][R] Renal failure syndrome
482: [P][R] Gastrointestinal hemorrhage
483: [P][R] Biliary cirrhosis
484: [P][R] End-stage renal disease
485: [P][R] Low back pain
486: [P][R] Premature rupture of membranes
487: [P][R] Celiac disease
488: [P][R] Diarrhea
489: [P][R] Acute renal failure syndrome
490: [P][R] Viral hepatitis C
491: [P][R] Malignant tumor of urinary bladder
492: [P][R] Cardiogenic shock
493: [P][R] Malignant tumor of cervix
494: [P][R] Primary malignant neoplasm of kidney
495: [P][R] Acute pancreatitis
496: [P][R] Abdominal pain
497: [P][R] Autoimmune hepatitis
498: [P][R] Toxic shock syndrome
499: [P][R] Type 1 diabetes mellitus
500: [P][R] Gastritis
501: [P][R] Crohn's disease
502: [P][R] Kidney stone
503: [P][R] Type 2 diabetes mellitus
504: [P][R] Sj?gren's syndrome
505: [P][R] Cough
506: [P][R] Chronic obstructive lung disease
507: [P][R] Pneumonia
508: [P][R] Allergic rhinitis
509: [P][R] Systemic lupus erythematosus
510: [P][R] Acute myocardial infarction
511: [P][R] Dyspnea
512: [P][R] Thromboangiitis obliterans
513: [P][R] Atrial fibrillation
514: [P][R] Granulomatosis with polyangiitis
515: [P][R] Sleep apnea
516: [P][R] Thrombotic microangiopathy
517: [P][R] Acute febrile mucocutaneous lymph node syndrome
518: [P][R] Myocarditis
519: [P][R] Heart failure
520: [P][R] Hypertensive disorder
521: [P][R] Asthma
522: [P][R] Coronary arteriosclerosis
523: [P][R] Arteriosclerotic vascular disease
524: [P][R] Migraine
525: [P][R] Gastroesophageal reflux disease
526: [P][R] Orthostatic hypotension
527: [P][R] Acute respiratory failure
528: [P][R] Polyarteritis nodosa
529: [P][R] Cardiac arrest
530: [P][R] Peripheral vascular disease
531: [P][R] Angina pectoris
532: [P][R] Heart disease
533: [P][R] Otitis media
534: [P][R] Transient cerebral ischemia
535: [P][R] Acute disseminated encephalomyelitis
536: [P][R] Age related macular degeneration
537: [P][R] Sensorineural hearing loss
538: [P][R] Paralytic syndrome
539: [P][R] Multiple sclerosis
540: [P][R] Optic neuritis
541: [P][R] Idiopathic peripheral neuropathy
542: [P][R] Cerebral hemorrhage
543: [P][R] Seizure
544: [P][R] Encephalitis
545: [P][R] Headache
546: [P][R] Retinal detachment
547: [P][R] Retinal disorder
549: [P][R] Epilepsy
550: [P][R] Chronic inflammatory demyelinating polyradiculoneuropathy
551: [P][R] Microcephaly
552: [P][R] Parkinson's disease
553: [P][R] Cerebrovascular accident
554: [P][R] Cerebrovascular disease
555: [P][R] Blood coagulation disorder
556: [P][R] Amyloidosis
557: [P][R] Angioedema
558: [P][R] Hyperlipidemia
559: [P][R] Thrombocytopenic disorder
560: [P][R] Pancytopenia
561: [P][R] Myasthenic syndrome due to another disorder
562: [P][R] Edema
563: [P][R] Obesity
564: [P][R] Hidradenitis
565: [P][R] Tuberculosis
566: [P][R] Kaposi's sarcoma (clinical)
567: [P][R] B-cell lymphoma (clinical)
568: [P][R] Hyperkalemia
569: [P][R] Systemic inflammatory response syndrome
570: [P][R] Leukopenia
571: [P][R] Schizophrenia
572: [P][R] Psychotic disorder
573: [P][R] Chronic pain
574: [P][R] Narcolepsy
575: [P][R] Behcet's syndrome
576: [P][R] Bipolar disorder
577: [P][R] Posttraumatic stress disorder
578: [P][R] Insomnia
579: [P][R] Ankylosing spondylitis
580: [P][R] Respiratory syncytial virus infection
581: [P][R] Multiple myeloma
582: [P][R] Bleeding
583: [P][R] Glaucoma
584: [P][R] Fever
585: [P][R] Hypokalemia
586: [P][R] Opioid dependence
587: [P][R] Opioid abuse
588: [P][R] Attention deficit hyperactivity disorder
589: [P][R] Pre-eclampsia
590: [P][R] Human immunodeficiency virus infection
591: [P][R] Autism spectrum disorder
592: [P][R] Anemia
593: [P][R] Paralysis
594: [P][R] Depressive disorder
595: [P][R] Pulmonary embolism
596: [P][R] Gout
597: [P][R] Takayasu's disease
598: [P][R] Methicillin resistant Staphylococcus aureus infection
599: [P][R] Anaphylaxis
600: [P][R] Open-angle glaucoma
601: [P][R] Vomiting
602: [P][R] Anxiety
603: [P][R] Human papilloma virus infection
604: [P][R] Cranial nerve disorder
605: [P][R] Muscle pain
606: [P][R] Stillbirth
607: [P][R] Malignant tumor of stomach
608: [P][R] Malignant neoplastic disease
609: [P][R] Cerebral infarction
610: [P][R] Eclampsia
611: [P][R] Diabetic ketoacidosis
612: [P][R] Acute tubular necrosis
613: [P][R] Tachycardia
614: [P][R] Venous thrombosis
615: [P][R] Herpes simplex
616: [P][R] Acute arthritis
617: [P][R] Monoclonal gammopathy (clinical)
618: [P][R] Pulmonary arterial hypertension
619: [P][R] Gestational diabetes mellitus
620: [P][R] Uveitis
621: [P][R] Renal impairment
622: [P][R] Non-Hodgkin's lymphoma (clinical)
623: [P][R] Motor neuropathy with multiple conduction block
624: [P][R] Primary sclerosing cholangitis
625: [P][R] Pustular psoriasis
626: [P][R] Cirrhosis of liver
627: [P][R] Miscarriage
628: [P][R] Fisher's syndrome
629: [P][R] Inflammatory bowel disease
630: [P][R] Facial palsy
631: [P][R] Livebirth
632: [P][R] Antiphospholipid syndrome
633: [P][R] Waldenstr?m macroglobulinemia
634: [P][R] Immunoglobulin A vasculitis
635: [P][R] Ventricular tachycardia
636: [P][R] Malignant tumor of breast
637: [P][R] Peripheral ischemia
638: [P][R] Neoplasm of thyroid gland
639: [P][R] Deep venous thrombosis
640: [P][R] Vasculitis
641: [P][R] Pericarditis
642: [P][R] Immune reconstitution syndrome
643: [P][R] Follicular non-Hodgkin's lymphoma
644: [P][R] Malignant tumor of prostate
645: [P][R] Guillain-Barr? syndrome
646: [P][R] Bradycardia
647: [P][R] Retinopathy due to diabetes mellitus
648: [P][R] Malignant tumor of colon
649: [P][R] Malignant tumor of esophagus
650: [P][R] Malignant tumor of ovary
651: [P][R] Dementia
652: [P][R] Vasculitis of the skin
653: [P][R] Loss of sense of smell
654: [P][R] Ischemic heart disease
655: [P][R] Aseptic meningitis
656: [P][R] Fatigue
657: [P][R] Paresthesia
658: [P][R] Hepatic failure
659: [P][R] Malignant neoplasm of liver
660: [P][R] Juvenile rheumatoid arthritis
661: [P][R] Respiratory failure
662: [P][R] Diverticulitis of large intestine
663: [P][R] Influenza
664: [P][R] Malaise
665: [P][R] Suicidal thoughts
666: [P][R] Type B viral hepatitis
667: [P][R] Guttate psoriasis
668: [P][R] SLE glomerulonephritis syndrome
669: [P][R] Schizoaffective disorder
670: [P][R] Temporal arteritis
671: [P][R] Pregnant
672: [P][R] Sense of smell impaired
673: [P][R] Primary malignant neoplasm of respiratory tract
674: [P][R] Degeneration of retina
675: [P][R] Pulmonary hypertension
676: [P][R] Necrosis of artery
677: [P][R] Preterm labor with preterm delivery
678: [P][R] COVID-19
679: [P][R] Takotsubo cardiomyopathy
680: [P][R] Mantle cell lymphoma
681: [P][R] Malignant neoplasm of anorectum
682: [P][R] Marginal zone lymphoma
683: [P][R] Antineutrophil cytoplasmic antibody positive vasculitis
684: [P][R] Sensory disorder of smell and/or taste
685: [P][R] Cardiac arrhythmia
686: [P][R] Fracture of bone of hip region
687: [P][R] Chronic kidney disease
688: [P][R] Death
689: [P][R] Newborn death
690: [P][R] Suicide
695: [P][R] Optic nerve glioma
696: [P][R] Neurofibromatosis type 2
697: [P][R] Neurofibromatosis type 1
698: [P][R] Neurofibromatosis syndrome
699: [P][R] Major Depressive Disorder
701: [P][R] Ascites
709: [P][R] Chronic liver disease
711: [P][R] Transplanted liver present
714: [P][R] Endometriosis (clinical)
794: [W] Hemorrhage of digestive system
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 14 were added.
1093: [P] Abdominal Aoritc Aneurysm repair - post op new Afib (any)
1094: [P] Lower Extremity Bypass - post op new Afib (any)
1095: [P] Carotid Endarterectomy - post op new Afib (any)
1096: [P] Lung Resection - post op new Afib (any)
1097: [P] Esophagectomy - post op new Afib (any)
1098: [P] Pancreatectomy - post op new Afib (any)
1099: [P] Colectomy - post op new Afib (any)
1100: [P] Cystectomy - post op new Afib (any)
1101: [P] Nephrectomy - post op new Afib (any)
1102: [P] Coronary Artery Bypass Graft Surgery - post op new Afib (any)
1103: [P] Aortic or Mitral Valve Repair or Replacement - post op new Afib (any)
1104: [P] RBC Transfusion (adult relevant, no auto 1yr clean window)
1105: [P] Clostridium difficile - first episode
1106: [P] Non-Emergent Major Non Cardiac Surgery no prior Opioid
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: No new cohorts were added in this release.
Deleted: 995, 988, 985, 984, 983, 975, 970, 969, 937, 899. Duplicate cohorts from LEGEND Diabetes Import.
Some fixes to issues with meta data for Cohorts
-
getPhenotypeLog() now returns the original user submitted cohort name, instead of the name forced by atlas-phenotype.
-
This is in line with the original requirement. It allows for long names, names with special characters.
-
Deprecated listPhenotypes(). This was an older function that did the same as getPhenotypeLog() but returned only two fields.
-
Added requirement on R (4.10) because tidyverse seems to cause problems with older versions of R.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: No new cohorts were added in this release.
Deleted Cohorts: duplicates. Added in error. Deleted 879, 907, 910, 916, 958, 959, 960, 961
Added new function getPlConceptDefinitionSet() . This new function exposes the concept sets from all circe compatible cohort definitions that are in the library.
Additional computer generated metadata added to cohort definition log.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 20 were added.
1072: [P] CMV Anterior Uveitis
1073: [P] Serious Infection, opportunistic infections and other infections of interest event
1074: [P] Serious Infection
1075: [P] FDA AESI Narcolepsy
1076: [P] FDA AESI Anaphylaxis
1077: [P] FDA AESI Anaphylaxis v2
1078: [P] FDA AESI Bells Palsy
1079: [P] FDA AESI Encephalomyelitis
1080: [P] FDA AESI Guillain Barre Syndrome
1081: [P] FDA AESI Acute Myocardial Infarction
1082: [P] FDA AESI Myocarditis Pericarditis
1083: [P] FDA AESI Immune Thrombocytopenia (ITP)
1084: [P] FDA AESI Disseminated Intravascular Coagulation
1085: [P] FDA AESI Appendicitis
1086: [P] FDA AESI Transverse Myelitis
1087: [P] FDA AESI Hemorrhagic Stroke
1088: [P] FDA AESI Deep Vein Thrombosis (DVT)
1089: [P] FDA AESI Non-hemorrhagic Stroke
1090: [P] FDA AESI Pulmonary Embolism
1091: [P] FDA AESI Thrombosis with Thrombocytopenia (TWT)
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 37 were added.
1035: [P] New users of Thiazide diuretics
1036: [P] New users of Beta blockers
1037: [P] New users of SGLT2 inhibitor
1038: [P] New users of GLP-1 receptor antagonists
1039: [P] New users of DPP-4 inhibitors
1040: [P] New users of Tumor Necrosis Factor alpha (TNFa) inhibitors
1041: [P] New users of JAK inhibitors
1042: [P] New users of IL-23 inhibitors
1043: [P] New users of Fluoroquinolone systemic
1044: [P] New users of Cephalosporin systemetic
1045: [P] New users of Trimethoprim systemetic
1046: [P] New users of Thiazide diuretics nested in essential hypertension
1047: [P] New users of dihydropyridine calcium channel blockers nested in essential hypertension
1048: [P] New users of dihydropyridine calcium channel blockers
1049: [P] New users of Beta blockers nested in essential hypertension
1050: [P] New users of Beta blockers nested in Left Heart Failure
1051: [P] New users of SGLT2 inhibitor nested in Left Heart Failure
1052: [P] New users of Beta blockers nested in Acute Myocardial Infarction
1053: [P] New users of GLP-1 receptor antagonists nested in Type 2 diabetes mellitus
1054: [P] New users of SGLT2 inhibitor nested in Type 2 diabetes mellitus
1055: [P] New users of DPP-4 inhibitors nested in Type 2 diabetes mellitus
1056: [P] New users of GLP-1 receptor antagonists nested in obesity
1057: [P] New users of IL-23 inhibitors nested in Plaque psoriasis
1058: [P] New users of Tumor Necrosis Factor alpha (TNFa) inhibitors nested in Plaque psoriasis
1059: [P] New users of Tumor Necrosis Factor alpha (TNFa) inhibitors nested in Psoriatic Arthritis
1060: [P] New users of Fluoroquinolone systemic nested in Urinary Tract Infection
1061: [P] New users of Cephalosporin systemetic nested in Urinary Tract Infection
1062: [P] New users of Trimethoprim systemetic nested in Urinary Tract Infection
1063: [P] New users of Fluoroquinolone systemic nested in Acute Typical Pneumonia
1064: [P] New users of Cephalosporin systemetic nested in Acute Typical Pneumonia
1065: [P] New users of Trimethoprim systemetic nested in Acute Typical Pneumonia
1066: [P] New users of Tumor Necrosis Factor alpha (TNFa) inhibitors nested in Rheumatoid arthritis
1067: [P] New users of JAK inhibitors nested in Ulcerative colitis
1068: [P] New users of Tumor Necrosis Factor alpha (TNFa) inhibitors nested in Ulcerative colitis
1069: [P] New users of Tumor Necrosis Factor alpha (TNFa) inhibitors nested in Crohns disease
1070: [P] New users of JAK inhibitors nested in Rheumatoid arthritis
1071: [P] persons at risk at start of year 2012-2022 with 365d prior observation
This release includes the bulk of the cohorts submitted to the OHDSI PhenotypeLibrary in the month of September 2023, as part of the push for HowOften.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 252 were added.
311: [P] Parasomnia
742: [P] Parasomnia or Sleep dysfunction with arousal disturbance
743: [P] Diabetic ketoacidosis IP-ER (SNOMED concept)
744: [P] Pulmonary Hypertension
745: [P] Inflammatory Bowel Disease
746: [P] Chronic Thromboembolic Pulmonary Hypertension
747: [P] Pulmonary Arterial Hypertension
748: [P] Psoriatic arthritis
749: [P] Plaque Psoriasis
750: [P] Pulmonary hypertension associated with left heart disease (WHO Group 2)
751: [P] Pulmonary hypertension associated with lung diseases and or hypoxia (WHO Group 3)
752: [P] Firearm Accidents (FA)
753: [P] Motor Vehicle Accidents (MVA)
754: [P] Down Syndrome
755: [P] Non-infectious uveitis and iridocyclitis
756: [P] Cystic Fibrosis
757: [P] Concomitant TNF - alpha Inhibitors and IL23 Inhibitors - GE 30D overlap
759: [P] Concomitant TNF - alpha Inhibitors and IL12_23 Inhibitors - GE 30D overlap
760: [P] Concomitant IL 23 Inhibitors and IL12_23 Inhibitors - GE 30D overlap
761: [P] Pulmonary arterial hypertension with Prior Left Heart or Vice Versa
762: [P] Endothelin receptor antagonists
763: [P] Phosphodiesterase 5 inhibitors and guanylate cyclase stimulators
764: [P] Prostacyclin analogues and prostacyclin receptor agonists
765: [P] Earliest event of Left Heart Failure
766: [P] Earliest event of Right Heart Failure
767: [P] Earliest event of Sarcoidosis
768: [P] Earliest event of Sickle Cell Anemia
769: [P] Scleroderma, first occurrence
770: [P] Essential Hypertension, first occurrence
771: [P] Pulmonary Hypertension (Group 2 Left heart disease, encompassing)
772: [P] Pulmonary Hypertension (Group 3 Chronic lung disease, encompassing)
773: [P] Congenital Heart Disease
774: [P] Portal Hypertension, first occurrence
775: [P] First Inflammatory Bowel Disease
776: [P] Antisynthetase syndrome
777: [P] Mixed connective tissue disease
778: [P] Undifferentiated connective tissue disease
779: [P] Overlap syndrome
780: [P] Raynaud?s disease or Raynaud's phenomenon
781: [P] Antiphospholipid syndrome
782: [P] CTEPH Prevalent (with Echo or RHC) with 2nd dx code 31-365 days after first dx
783: [P] Pulmonary endarterectomy
784: [P] Balloon Pulmonary Angioplasty
785: [P] Skin Burns
786: [P] Non-small cell lung cancer (NSCLC)
787: [P] Lung cancer
788: [P] Breast cancer
789: [P] Glioblastoma multiforme (GBM)
790: [P] Colorectal Cancer
791: [P] Multiple Myeloma
792: [P] Metastatic Hormone-Sensitive Prostate Cancer Synchronous
793: [P] Metastatic Hormone-Sensitive Prostate Cancer Metachronus
794: COPY OF [P][R] Bleeding
795: [P] Antineoplastic drugs against colorectal cancer
796: [P] Potential curative surgery for colorectal cancer
797: [P] Radiotherapy against colorectal cancer
798: [P] Primary adenocarcinoma of the colon or rectum
802: [P] Acute Respiratory Failure 2
803: [P] Fascial dehiscence and evisceration
804: [P] Anastomotic leak or dehiscence
805: [P] Intestinal obstruction (broad)
806: [P] Intraabdominal abscess
807: [P] Perioperative aspiration
808: [P] Postoperative hemorrhage
809: [P] Surgical wound infection (narrow)
810: [P] Distant metastasis following colorectal cancer (wide)
811: [P] Local recurrence after colorectal cancer
812: [P] Primary adenocarcinoma of the colon or rectum, MSI-H or dMMR, no surgery or oncological treatment
813: [P] Primary adenocarcinoma of the colon or rectum treated with potentially curative surgery
814: [P] Primary adenocarcinoma of the colon or rectum, no curative intended surgery and oncological treatment
817: [P] Primary adenocarcinoma of the colon or rectum, no curative intended surgery and oncological treatment2
818: [P] Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR
819: [P] Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, treated with curative intended surgery
820: [P] Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no curative surgery
821: [P] Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
822: [P] Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, surgical treatment
823: [P] Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, oncological treatment no surgery
824: [P] Primary adenocarcinoma of colon or rectum, MSI-H or dMMR
825: [P] Primary adenocarcinoma of colon
826: [P] Primary adenocarcinoma of colon, no surgery or oncological treatment
827: [P] Primary adenocarcinoma of colon surgical treatment
828: [P] Primary adenocarcinoma of colon oncological treatment, no surgery
829: [P] Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR
830: [P] Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR, surgically treated
831: [P] Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
832: [P] Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
833: [P] Primary adenocarcinoma of colon MSI-H or dMMR
834: [P] Primary adenocarcinoma of colon MSI-H or dMMR, surgical treatment
835: [P] Primary adenocarcinoma of colon MSI-H or dMMR, oncological treatment, no surgery
836: [P] Primary adenocarcinoma of colon MSI-H or dMMR, no surgery or oncological treatment
837: [P] Primary adenocarcinoma of rectum
838: [P] Primary adenocarcinoma of rectum MSI-H or dMMR
839: [P] Primary adenocarcinoma of rectum, MSI-H or dMMR, no surgery or oncological treatment
840: [P] Primary adenocarcinoma of rectum MSI-H or dMMR, oncological treatment, no surgery
841: [P] Primary adenocarcinoma of rectum, MSI-H or dMMR, surgical treatment
842: [P] Primary adenocarcinoma of rectum, MSI-L, MSI-indeterminate, MSS or pMMR
843: [P] Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
844: [P] Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, no surgery and no oncological treatment
845: [P] Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, treated with potentially curative surgery
846: [P] Primary adenocarcinoma of rectum oncological treatment, no surgery
847: [P] Primary adenocarcinoma of rectum surgical treatment
848: [P] Primary adenocarcinoma of rectum, no surgery or oncological treatment
850: [P] Intestinal obstruction (broad 2)
851: [P] Intraabdominal obstruction (broad)
852: [P] Surgical wound infection (broad)
854: [P] Distant metastasis following colorectal cancer (medium)
855: [P] Distant metastasis following colorectal cancer (narrow)
856: [P] Earliest event of Migraine, including history of migraine
857: [P] Earliest event of Migraine
858: [P] Earliest event of Rheumatoid Arthritis
859: [P] Earliest event of Crohns disease
860: [P] Earliest event of Ulcerative colitis
861: [P] Earliest event of Urinary tract infections (UTI)
862: [P] Earliest event of Alzheimer's disease derived from Imfeld, 2
863: [P] Cognitive impairment, incident
864: [P] Earliest event of Dementia
865: [P] Non-Emergent Major Non Cardiac Surgery
866: [P] AAA repair
867: [P] Lower Extremity Bypass
868: [P] Carotid Endarterectomy
869: [P] Lung Resection
870: [P] Esophagectomy
871: [P] Pancreatectomy
872: [P] Colectomy
873: [P] Cystectomy
874: [P] Nephrectomy
875: [P] Coronary Artery Bypass Graft Surgery
876: [P] Aortic or Mitral Valve Repair or Replacement
877: [P] Non-Emergent MNCS (age 18 or greater), post op Afib (parox)
878: [P] Non-Emergent MNCS (age 18 or greater), post op Afib (any)
879: Cxxx Endometriosis indexed on procedure with two or more diagnosis among females 15 to 49
881: [P] Acute myocardial infarction
882: [P] Decreased libido
884: [P] Diarrhea2
888: [P] Gastrointestinal bleeding
889: [P] Hyponatremia
890: [P] Hypotension
891: [P] Nausea
892: [P] Stroke
893: [P] Vertigo
894: [P] Abdominal pain
895: [P] Abnormal weight gain
896: [P] Abnormal weight loss
898: [P] Acute renal failure
899: [P] All-cause mortality
900: [P] Anaphylactoid reaction
901: [P] Anemia
907: [P] All-cause mortality2
910: [P] Anaphylactoid reaction2
913: [P] Anemia2
916: [P] Angioedema2
917: [P] Anxiety
918: [P] Bradycardia
919: [P] Cardiac arrhythmia
920: [P] Cardiovascular disease
921: [P] Cardiovascular-related mortality
922: [P] Chest pain or angina
923: [P] Kidney disease
924: [P] Coronary heart disease
925: [P] Cough
927: [P] Dementia2
928: [P] Depression2
929: [P] Edema2
930: [P] End stage renal disease2
931: [P] Fall2
932: [P] Gout2
933: [P] Headache2
934: [P] Heart failure2
935: [P] Hemorrhagic stroke2
936: [P] Hepatic failure2
937: [P] Hospitalization with heart failure2
938: [P] Hospitalization with heart failure
939: [P] Hospitalization with preinfarction syndrome
940: [P] Hyperkalemia
941: [P] Hypokalemia
942: [P] Hypomagnesemia
943: [P] Impotence
944: [P] Ischemic stroke
945: [P] Malignant neoplasm
946: [P] Measured renal dysfunction
947: [P] Neutropenia or agranulocytosis
948: [P] Rash
950: [P] Rhabdomyolysis2
953: [P] Sudden cardiac death
954: [P] Syncope
955: [P] Thrombocytopenia
956: [P] Transient ischemic attack
957: [P] Type 2 diabetes mellitus
958: [P] Syncope3
959: [P] Thrombocytopenia3
960: [P] Transient ischemic attack3
961: [P] Type 2 diabetes mellitus3
963: [P] Vomiting
964: [P] Chronic kidney disease
965: [P] 3-point MACE
967: [P] 4-point MACE
969: [P] Acute myocardial infarction2
970: [P] 4-point MACE2
975: [P] Acute renal failure2
976: [P] Glycemic control2
979: [P] Hospitalization with heart failure3
980: [P] Revascularization
982: [P] Stroke2
983: [P] Sudden cardiac death2
984: [P] Abnormal weight gain2
985: [P] Abnormal weight loss2
986: [P] Acute pancreatitis2
988: [P] All-cause mortality3
989: [P] Bladder cancer3
990: [P] Bone fracture3
991: [P] Breast cancer3
992: [P] Diabetic ketoacidosis3
993: [P] Diarrhea3
994: [P] Genitourinary infection3
995: [P] Hyperkalemia3
996: [P] Hypoglycemia3
997: [P] Hypotension3
998: [P] Joint pain3
999: [P] Lower extremity amputation3
1000: [P] Nausea3
1001: [P] Peripheral edema3
1002: [P] Photosensitivity3
1003: [P] Renal cancer3
1004: [P] Thyroid tumor3
1005: [P] Venous thromboembolism3
1006: [P] Vomiting3
1007: [P] Earliest event of Epilepsy
1009: [P] Earliest event of Treatment resistant depression (TRD)
1010: [P] Earliest event of Chronic Graft Versus Host Disease (GVHD)
1011: [P] Earliest event of Marginal zone lymphoma
1012: [P] Earliest event of Waldenstrom macroglobulinemia
1013: [P] Earliest event of Ankylosing Spondylitis
1015: [P] Earliest event of Pulmonary arterial hypertension (PAH)2
1016: [P] Earliest event of Polyarticular juvenile idiopathic arthritis (JIA)
1017: [P] Earliest event of Neonatal Thrombocytopenia (NT), less than 1 year old
1018: [P] Earliest event of Warm Autoimmune Hemolytic Anemia (wAIHA), occurring on or after October 2020
1019: [P] All events of Hemolytic Disease Fetus and Newborn (HDFN), RhD type, with a pregnancy episode
1020: [P] Earliest event of Major depressive disorder, with NO occurrence of certain psychiatric disorder
1021: [P] Earliest event of Myasthenia Gravis, inpatient, 2nd diagnosis or treatment, age gte 18
1022: [P] Earliest event of Depressive and Sleep Disorder
1023: [P] Earliest Event of Depressive Disorder with Suicidal Ideation or Attempt Prevalent
1024: [P] Earliest Event of Depressive Disorder with Anhedonia
1025: [P] First event of Attention-deficit hyperactivity (ADHD) disorder or procedure
1026: [P] Earliest Event of Multiple Sclerosis
1027: [P] Earliest event of Chronic Leukocytic Leukemia
1028: [P] Earliest event of Urothelial carcinoma
1029: [P] Earliest event of Mantle Cell Lymphoma
1030: [P] Earliest event of Prostate cancer, among adult males
1031: [P] Earliest event of Coronary artery disease (CAD)
1032: [P] Earliest event of Type 2 Diabetes Mellitus (DM), with no type 1 or secondary DM
1033: [P] Earliest event of Human Immunodeficiency Virus I (HIV), with treatment, lab or 2nd diagnosis
1034: [P] All events of Respiratory syncytial virus infection, with 30 days washout
This release is a clean up of files and cohorts before adding cohorts from HowOften. getPhenotypeLog() now gives additional information about a cohort. These are programmatically derived from Circe model compatible cohort json.
censorWindowStartDate censorWindowEndDate collapseSettingsType
collapseEraPad exitStrategy exitDateOffSetField exitDateOffSet
numberOfInclusionRules qualifyingLimitType primaryCriteriaLimit
numberOfCohortEntryEvents numberOfDomainsInEntryEvents
domainsInEntryEvents continousObservationWindowPrior
continousObservationWindowPost numberOfConceptSets
demographicCriteria demographicCriteriaAge demographicCriteriaGender
useOfObservationPeriodInclusionRule restrictedByVisit
domainConditionOccurrence domainMeasurement domainObservation
domainVisitOccurrence domainDeath domainDrugExposure
criteriaAgePrimaryCriteria domainDeviceExposure
domainProcedureOccurrence criteriaAgeInclusionRules
criteriaGenderPrimaryCriteria criteriaGenderInclusionRules
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: No new cohorts were added in this release.
Minor changes. Remove dependencies from suggests. Fix hyperlinks in vignettes.
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 39 were added.
701: [P][R] Ascites
702: [P] Alanine aminotransferase (ALT) elevated
703: [P] Aspartate aminotransferase (AST) elevated
705: [P] Total Bilirubin elevated
706: [P] Prothrombin time (PT) elevated
707: Inpatient Hospitalization (0Pe, 1Era)
708: [P] International normalized ratio (INR) elevated
709: [P][R] Chronic liver disease
710: [P] Cirrhosis of liver or its sequela
711: [P][R] Transplanted liver present
712: [P] Viral hepatitis including history of
713: [P] Alcoholic hepatitis or alcohol liver disorder
714: [P][R] Endometriosis (clinical)
715: [P] Hepatic fibrosis
716: [P] Acute Hepatic Injury
717: [P] Portal hypertension or esophageal varices
719: [P] Acute Hepatic Injury or jaundice while inpatient with no cooccurring certain liver disease
720: [P] Aplastic Anemia
721: [P] Sudden New Onset Blindness
722: [P] Endometriosis indexed on procedure with two or more diagnosis among females 15 to 49
723: [P] First Acute Hepatic Failure with no known severe liver disease
724: [P] First Acute Hepatic Failure with no known liver disease
725: [P] All events of Acute Kidney Injury (AKI), with a washout period of 30 days
726: [P] All events of Anaphylaxis, Mini-Sentinel
727: [P] All events of Angioedema, with a washout period of 180 days
728: [P] Autoimmune hemolytic anemia events not including evans syndrome
729: [P] Autoimmune hepatitis, with a washout period of 365 days
730: [P] Acute pancreatitis, indexed on visit with NO chronic or hereditary pancreatitis
731: [P] Sudden Hearing Loss, No congenital anomaly or middle or inner ear conditions
732: [P] Severe Cutaneous Adverse Reaction (SCAR = SJS+TEN+DRESS) with clean window
733: [P] Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) with clean window
734: [P] Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)
735: [P] Acute Liver Injury indexed on diagnosis or symptoms with no chronic hepatic failure
736: [P] Acute Liver Injury NO viral, alcoholic, chronic hepatic failure
737: [P] Neutropenic Fever, Inpatient or ER, indexed on fever or Infection, 90 days era
738: [P] Autoimmune hemolytic anemia
739: [P] All events of Isolated Immune Thrombocytopenia (ITP), with a washout period of 365 days
740: [P] Earliest event of Pulmonary arterial hypertension (PAH)
741: [P] Earliest event of Thrombotic microangiopathy (TMA) or Microangiopathic hemolytic anemia (MAHA)
Formatting and rewrite of vignettes.
Updated readme file and CohortDefinitionsubmissionRequirement document Removed some rogue files.
PhenotypeLibrary 3.16.0
Metadata documentation has improved in this release.
Reference Cohorts: 251 cohort definitions called reference cohorts have been added. These came from version 2 of the OHDSI PhenotypeLibrary. Those definitions are simple cohort definitions that have a template of one entry event criteria with conceptId and descendants. These have prefix of [P][R] in their name. There is also an indicator field called isReferenceCohort.
444: [P][R] Neck pain
445: [P][R] Hypoglycemia
446: [P][R] Eosinophilic esophagitis
447: [P][R] Esophagitis
448: [P][R] Dysphagia
449: [P][R] Nausea
450: [P][R] Constipation
451: [P][R] Myasthenia gravis
452: [P][R] Joint pain
453: [P][R] Osteoarthritis
454: [P][R] Dermatomyositis
455: [P][R] Fetal growth restriction
456: [P][R] Osteoporosis
457: [P][R] Rheumatoid arthritis
458: [P][R] Ulcerative colitis
459: [P][R] Urinary tract infectious disease
460: [P][R] Psoriasis with arthropathy
461: [P][R] Erythema multiforme
462: [P][R] Lichen planus
463: [P][R] Sepsis
464: [P][R] Myelofibrosis
465: [P][R] Thyroiditis
466: [P][R] Atopic dermatitis
467: [P][R] Systemic sclerosis
468: [P][R] Pityriasis rubra pilaris
469: [P][R] Jaundice
470: [P][R] Chronic lymphoid leukemia, disease
471: [P][R] Vitiligo
472: [P][R] Myelodysplastic syndrome (clinical)
473: [P][R] Acute transverse myelitis
474: [P][R] Pemphigoid
475: [P][R] Psoriasis
476: [P][R] Acute myeloid leukemia, disease
477: [P][R] Hypothyroidism
478: [P][R] Malignant melanoma of skin
479: [P][R] Chilblains
480: [P][R] Alopecia areata
481: [P][R] Renal failure syndrome
482: [P][R] Gastrointestinal hemorrhage
483: [P][R] Biliary cirrhosis
484: [P][R] End-stage renal disease
485: [P][R] Low back pain
486: [P][R] Premature rupture of membranes
487: [P][R] Celiac disease
488: [P][R] Diarrhea
489: [P][R] Acute renal failure syndrome
490: [P][R] Viral hepatitis C
491: [P][R] Malignant tumor of urinary bladder
492: [P][R] Cardiogenic shock
493: [P][R] Malignant tumor of cervix
494: [P][R] Primary malignant neoplasm of kidney
495: [P][R] Acute pancreatitis
496: [P][R] Abdominal pain
497: [P][R] Autoimmune hepatitis
498: [P][R] Toxic shock syndrome
499: [P][R] Type 1 diabetes mellitus
500: [P][R] Gastritis
501: [P][R] Crohn's disease
502: [P][R] Kidney stone
503: [P][R] Type 2 diabetes mellitus
504: [P][R] Sj?gren's syndrome
505: [P][R] Cough
506: [P][R] Chronic obstructive lung disease
507: [P][R] Pneumonia
508: [P][R] Allergic rhinitis
509: [P][R] Systemic lupus erythematosus
510: [P][R] Acute myocardial infarction
511: [P][R] Dyspnea
512: [P][R] Thromboangiitis obliterans
513: [P][R] Atrial fibrillation
514: [P][R] Granulomatosis with polyangiitis
515: [P][R] Sleep apnea
516: [P][R] Thrombotic microangiopathy
517: [P][R] Acute febrile mucocutaneous lymph node syndrome
518: [P][R] Myocarditis
519: [P][R] Heart failure
520: [P][R] Hypertensive disorder
521: [P][R] Asthma
522: [P][R] Coronary arteriosclerosis
523: [P][R] Arteriosclerotic vascular disease
524: [P][R] Migraine
525: [P][R] Gastroesophageal reflux disease
526: [P][R] Orthostatic hypotension
527: [P][R] Acute respiratory failure
528: [P][R] Polyarteritis nodosa
529: [P][R] Cardiac arrest
530: [P][R] Peripheral vascular disease
531: [P][R] Angina pectoris
532: [P][R] Heart disease
533: [P][R] Otitis media
534: [P][R] Transient cerebral ischemia
535: [P][R] Acute disseminated encephalomyelitis
536: [P][R] Age related macular degeneration
537: [P][R] Sensorineural hearing loss
538: [P][R] Paralytic syndrome
539: [P][R] Multiple sclerosis
540: [P][R] Optic neuritis
541: [P][R] Idiopathic peripheral neuropathy
542: [P][R] Cerebral hemorrhage
543: [P][R] Seizure
544: [P][R] Encephalitis
545: [P][R] Headache
546: [P][R] Retinal detachment
547: [P][R] Retinal disorder
549: [P][R] Epilepsy
550: [P][R] Chronic inflammatory demyelinating polyradiculoneuropathy
551: [P][R] Microcephalus
552: [P][R] Parkinson's disease
553: [P][R] Cerebrovascular accident
554: [P][R] Cerebrovascular disease
555: [P][R] Blood coagulation disorder
556: [P][R] Amyloidosis
557: [P][R] Angioedema
558: [P][R] Hyperlipidemia
559: [P][R] Thrombocytopenic disorder
560: [P][R] Pancytopenia
561: [P][R] Myasthenic syndrome due to another disorder
562: [P][R] Edema
563: [P][R] Obesity
564: [P][R] Hidradenitis
565: [P][R] Tuberculosis
566: [P][R] Kaposi's sarcoma (clinical)
567: [P][R] B-cell lymphoma (clinical)
568: [P][R] Hyperkalemia
569: [P][R] Systemic inflammatory response syndrome
570: [P][R] Leukopenia
571: [P][R] Schizophrenia
572: [P][R] Psychotic disorder
573: [P][R] Chronic pain
574: [P][R] Narcolepsy
575: [P][R] Behcet's syndrome
576: [P][R] Bipolar disorder
577: [P][R] Posttraumatic stress disorder
578: [P][R] Insomnia
579: [P][R] Ankylosing spondylitis
580: [P][R] Respiratory syncytial virus infection
581: [P][R] Multiple myeloma
582: [P][R] Bleeding
583: [P][R] Glaucoma
584: [P][R] Fever
585: [P][R] Hypokalemia
586: [P][R] Opioid dependence
587: [P][R] Opioid abuse
588: [P][R] Attention deficit hyperactivity disorder
589: [P][R] Pre-eclampsia
590: [P][R] Human immunodeficiency virus infection
591: [P][R] Autism spectrum disorder
592: [P][R] Anemia
593: [P][R] Paralysis
594: [P][R] Depressive disorder
595: [P][R] Pulmonary embolism
596: [P][R] Gout
597: [P][R] Takayasu's disease
598: [P][R] Methicillin resistant Staphylococcus aureus infection
599: [P][R] Anaphylaxis
600: [P][R] Open-angle glaucoma
601: [P][R] Vomiting
602: [P][R] Anxiety
603: [P][R] Human papilloma virus infection
604: [P][R] Cranial nerve disorder
605: [P][R] Muscle pain
606: [P][R] Stillbirth
607: [P][R] Malignant tumor of stomach
608: [P][R] Malignant neoplastic disease
609: [P][R] Cerebral infarction
610: [P][R] Eclampsia
611: [P][R] Diabetic ketoacidosis
612: [P][R] Acute tubular necrosis
613: [P][R] Tachycardia
614: [P][R] Venous thrombosis
615: [P][R] Herpes simplex
616: [P][R] Acute arthritis
617: [P][R] Monoclonal gammopathy (clinical)
618: [P][R] Pulmonary arterial hypertension
619: [P][R] Gestational diabetes mellitus
620: [P][R] Uveitis
621: [P][R] Renal impairment
622: [P][R] Non-Hodgkin's lymphoma (clinical)
623: [P][R] Motor neuropathy with multiple conduction block
624: [P][R] Primary sclerosing cholangitis
625: [P][R] Pustular psoriasis
626: [P][R] Cirrhosis of liver
627: [P][R] Miscarriage
628: [P][R] Fisher's syndrome
629: [P][R] Inflammatory bowel disease
630: [P][R] Facial palsy
631: [P][R] Livebirth
632: [P][R] Antiphospholipid syndrome
633: [P][R] Waldenstr?m macroglobulinemia
634: [P][R] Immunoglobulin A vasculitis
635: [P][R] Ventricular tachycardia
636: [P][R] Malignant tumor of breast
637: [P][R] Peripheral ischemia
638: [P][R] Neoplasm of thyroid gland
639: [P][R] Deep venous thrombosis
640: [P][R] Vasculitis
641: [P][R] Pericarditis
642: [P][R] Immune reconstitution syndrome
643: [P][R] Follicular non-Hodgkin's lymphoma
644: [P][R] Malignant tumor of prostate
645: [P][R] Guillain-Barr? syndrome
646: [P][R] Bradycardia
647: [P][R] Retinopathy due to diabetes mellitus
648: [P][R] Malignant tumor of colon
649: [P][R] Malignant tumor of esophagus
650: [P][R] Malignant tumor of ovary
651: [P][R] Dementia
652: [P][R] Vasculitis of the skin
653: [P][R] Loss of sense of smell
654: [P][R] Ischemic heart disease
655: [P][R] Aseptic meningitis
656: [P][R] Fatigue
657: [P][R] Paresthesia
658: [P][R] Hepatic failure
659: [P][R] Malignant neoplasm of liver
660: [P][R] Juvenile rheumatoid arthritis
661: [P][R] Respiratory failure
662: [P][R] Diverticulitis of large intestine
663: [P][R] Influenza
664: [P][R] Malaise
665: [P][R] Suicidal thoughts
666: [P][R] Type B viral hepatitis
667: [P][R] Guttate psoriasis
668: [P][R] SLE glomerulonephritis syndrome
669: [P][R] Schizoaffective disorder
670: [P][R] Temporal arteritis
671: [P][R] Pregnant
672: [P][R] Sense of smell impaired
673: [P][R] Primary malignant neoplasm of respiratory tract
674: [P][R] Degeneration of retina
675: [P][R] Pulmonary hypertension
676: [P][R] Microscopic polyarteritis nodosa
677: [P][R] Preterm labor with preterm delivery
678: [P][R] COVID-19
679: [P][R] Takotsubo cardiomyopathy
680: [P][R] Mantle cell lymphoma
681: [P][R] Malignant neoplasm of anorectum
682: [P][R] Marginal zone lymphoma
683: [P][R] Antineutrophil cytoplasmic antibody positive vasculitis
684: [P][R] Sensory disorder of smell and/or taste
685: [P][R] Cardiac arrhythmia
686: [P][R] Fracture of bone of hip region
687: [P][R] Chronic kidney disease
688: [P][R] Death
689: [P][R] Newborn death
690: [P][R] Suicide
695: [P][R] Optic nerve glioma
696: [P][R] Neurofibromatosis type 2
697: [P][R] Neurofibromatosis type 1
698: [P][R] Neurofibromatosis syndrome
699: [P][R] Major Depressive Disorder
Accepted Cohorts: No cohorts were accepted in this release. Four new cohorts have been added. These are minor modifications of previously published cohorts.
691: Transverse myelitis or symptoms indexed on symptoms or diagnosis
692: Transverse myelitis indexed on diagnosis
693: Acquired Neutropenia or unspecified leukopenia
694: Appendicitis during Inpatient visit
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 7 were added.
410: [P] Acute Urinary tract infections UTI (1Pe, 30Era)
411: [P] Sepsis or Septic Shock (1Pe, 7Era)
412: Transverse myelitis indexed on diagnosis (1Ps, 0Era, 365W)
414: [P] Acute Skin Eruption symptoms (1Pe, 7Era)
415: [P] Skin Erythema (1Pe, 7Era)
416: [P] Skin Rash (1Pe, 7Era)
417: [P] Acute gastrointestinal bleeding events (7Pe, 30Era)
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 44 were added.
363: [P] Joint Stiffness (3Pe, 7Era)
364: [P] Sleep disorder (3Pe, 7Era)
365: [P] Dysuria (3Pe, 7Era)
366: [P] Streptococcal throat infection (14Pe, 30Era)
367: [P] Allergic Rhinitis (14Pe, 30Era)
368: [P] Sinusitis (7Pe, 30Era)
369: [P] Allergic condition (14Pe, 30Era)
370: [P] Allergic disorder (14Pe, 30Era)
371: [P] Claudication Pain (365Pe, 365Era)
372: [P] Otitis media (3Pe, 30Era)
373: [P] Iron deficiency Anemia (365Pe, 365Era)
374: [P] Drug Dependence Disorder (30Pe, 365Era)
375: [P] Gall stone disorder (30Pe, 365Era)
376: [P] Skin Bleeding (1Pe, 7Era)
377: [P] Skin Petechiae (1Pe, 7Era)
378: [P] Skin Purpura (1Pe, 7Era)
379: [P] Ecchymosis (1Pe, 7Era)
380: [P] Jaundice (1Pe, 7Era)
381: [P] Skin Itching (1Pe, 7Era)
382: [P] Prurititc Rash (1Pe, 7Era)
383: [P] Eczematous Atopic Dermatitis and non hyperkeratotic dermatosis (1Pe, 365Era)
384: [P] Contact Dermatitis (14Pe, 60Era)
385: [P] Intertrigo (14Pe, 60Era)
386: [P] Seborrheic dermatitis (14Pe, 60Era)
387: [P] Photodermatitis (14Pe, 60Era)
388: [P] Peripheral Neuritis (FP)
389: [P] Peripheral Neuropathy or Neuritits (FP)
391: [P] Hearing Loss (30Pe, 365Era)
392: [P] Otalgia or Otitis (3Pe, 30Era)
393: [P] Low Back Pain or Injury (3Pe, 7Era)
394: [P] Gastroesophageal reflux disease (365Pe, 365Era)
395: [P] Dysmenorrhea (90Pe, 365Era)
396: [P] Osteoarthritis (FP)
397: [P] Benign Prostatic Hyperplasia (FP)
398: [P] Bladder Outflow Obstruction (0Pe, 180Era)
399: [P] Kidney Stone (1Pe, 30Era)
400: [P] Prostate Cancer among adult males (FP)
401: [P] Uterine Fibroids (FP)
402: [P] Ventilatory assist for respiratory findings with Acute Respiratory Failure (0Pe, 0Era)
403: [P] Acute Respiratory Failure in inpatient or Emergency room (0Pe, 0Era)
404: [P] Ventricular Tachycardia, in an Inpatient or Emergency room setting (1Pe, 7Era)
405: [P] Atrial Fibrillation or Flutter (1Pe, 365Era)
406: [P] Intellectual Disability (FP)
407: [P] Hemorrhoids (1Pe, 30Era)
Accepted Cohorts: 5 cohorts were accepted in this release.
304: Neurofibromatosis type 1 (FP)
305: Neurofibromatosis type 1 without Type 2 (FP)
306: Optical pathway glioma and neurofibromatosis (FP)
307: Optical pathway glioma or non malignant neoplasm of optic nerve w neurofibromatosis (FP)
308: Optical pathway glioma with MRI imaging and ophthalmology visits Neurofibromatosis (FP)
New Cohorts: 7 were added.
361: [P] Restless Leg Syndrome (FP)
362: [P] Acute Kidney Injury AKI (7Pe, 30W)
Accepted Cohorts: No cohorts were accepted in this release.
New Cohorts: 13 were added.
348: [P] Hematuria (7Pe, 30Era)
349: [P] Lower gastrointestinal bleeding events (7Pe, 30Era)
350: [P] Hemoptysis (7Pe, 30Era)
351: [P] Nasal Polyp (365Pe, 365Era)
352: [P] Inflamed Tonsil (7Pe, 30Era)
353: [P] Conjunctivitis (3Pe, 7Era)
354: [P] Nasal Congestion or Rhinitis or Common Cold (3Pe, 7Era)
355: [P] Laryngitis (3Pe, 7Era)
356: [P] Epistaxis (3Pe, 7Era)
357: [P] Pulmonary Edema (3Pe, 30Era)
358: [P] Acute Respiratory Failure among persons with no chronic respiratory failure (3Pe, 30Era)
359: [P] Acute Respiratory Failure (3Pe, 30Era)
360: [P] Pleural Effusion (3Pe, 30Era)
Accepted Cohorts: 2 were accepted. 234: Appendicitis (1Pe, 180Era) 213: Acquired Neutropenia or unspecified leukopenia (21Pe, 365Era)
New Cohorts: 9 were added.
339: [P] Hypotension (1Pe, 3Era)
340: [P] Hives, Erythema, Eruption, Urticaria (1Pe, 7Era)
341: [P] Loss of mentation including coma, loss of consciousness, altered consciousness (1Pe, 3Era)
342: [P] Urinary Incontinence (1Pe, 3Era)
343: [P] Fecal Incontinence (1Pe, 3Era)
344: [P] Doctors office or clinic visit without other overlapping visits (0Pe, 0Era)
345: [P] Doctors office or clinic visit (0Pe, 0Era)
346: [P] Non urgent outpatient visit without overlapping inpatient or emergency visit (0Pe, 0Era)
347: [P] Ambulance utilization (0Pe, 0Era)
Accepted Cohorts: The following cohorts were added
119: Systemic lupus erythematosus indexed on signs, symptoms, treatment or diagnosis (FP)
296: Transverse myelitis or symptoms indexed on symptoms or diagnosis (180Pe, 180Era)
New Cohorts: 17 were added.
142: [P] Earliest event of ST elevated myocardial infarction (7P, 1E)
192: [P] Skin or mucosal bleeding events (1Pe, 7Era)
298: [P] Urinary bleed events in persons without renal glomerular disease (30Pe, 7Era)
299: [P] Acute gastrointestinal bleeding events (7Pe, 30Era)
300: [P] Heavy menstrual bleeding (menorrhagia) events (60Pe, 180Era)
318: [P] All events of Acute Hepatic Failure in persons without chronic hepatic failure (90Pe, 365Era)
324: [P] Pain (3Pe, 7Era)
325: [P] Inpatient Hospitalization By Site of care or type of service (0Pe, 1Era)
327: [P] Pharyngitis (3Pe, 7Era)
328: [P] Wheezing (3Pe, 30Era)
329: [P] Pneumonitis and lung infections (14Pe, 30Era)
330: [P] Abdominal Bloating (1Pe, 7Era)
331: [P] Encephalopathy (1Pe, 14Era)
332: [P] Pain or ache that is Chronic (3Pe, 180Era)
333: [P] Alcohol Use Disorder (365Pe, 365Era)
334: [P] Asthma (FP)
335: [P] Anxiety or Fear (3Pe, 30Era)
Deprecated Cohorts: No new cohorts were added in this release.
New Cohorts: 19 were added.
134: [P] Persons with Attention Deficit Hyperactivity Disorder (FP)
278: [P] Pain that is Non Chronic, Non Generalized (3Pe, 7Era)
279: [P] Low Back Pain (30Pe, 180Era)
280: [P] Abdominal Pain (3Pe, 7Era)
281: [P] Epigastric Pain (3Pe, 7Era)
282: [P] Joint Pain (3Pe, 30Era)
283: [P] Prostatitis (180Pe, 365Era)
284: [P] Myocarditis or Pericarditis (30Pe, 90Era)
285: [P] Myocarditis or Pericarditis Not due to infections (30Pe, 90Era)
287: [P] Transverse myelitis includes Myelitis Unspecified and neuromyelitis optica (90Pe, 365Era)
288: [P] Type 2 Diabetes Mellitus indexed on diagnosis, treatment or lab results (FP)
289: [P] Presence Of Cardiac Arrhythmia (3Pe, 60Era)
290: [P] Thyroiditis indexed on diagnosis or treatment without (FP)
291: [P] Gynecomastia, indexed on diagnosis, procedure or symptoms (FP)
292: [P] Hepatic Failure (365Pe, 365Era)
293: [P] Acute Hepatic Injury with no chronic hepatic failure (180Pe, 180Era)
294: [P] Acute Hepatic Injury with no pre-existing liver disease (180Pe, 180Era)
295: [P] Acute Hepatic Failure in persons with no pre-existing liver disease (365Pe, 365Era)
296: Transverse myelitis or symptoms indexed on symptoms or diagnosis (180Pe, 180Era)
Deprecated Cohorts: No new cohorts were added in this release.
Accepted Cohorts: The following cohorts were added
269: Acute Kidney Injury AKI (7Pe, 30W)
Discussed https://forums.ohdsi.org/t/phenotype-phebruary-day-29-acute-kidney-injury/16067 and peer reviewed by Azza Shoaibi and accepted after modifications. See recording dated August 12th 2022
New Cohorts: 2 were added.
276: [P] Sudden Vision Loss (1Pe, 0Era, 365W)
277: [P] Sudden Hearing Loss (1Pe, 0Era, 365W)
Deprecated Cohorts: No new cohorts were added in this release.
Accepted Cohorts: The following cohorts were added
63: Transverse myelitis or symptoms (1Ps, 0Era, 365W)
Deprecated Cohorts: No new cohorts were added in this release.
Modified Cohorts: several symptom and sign based cohorts were updated to support discussion https://forums.ohdsi.org/t/phenotype-submission-symptoms-and-signs/17895
New Cohorts: 2 were added.
270: [P] Hemolytic Anemia (7Pe, 0Era, 365W)
271: [P] Hemolytic Anemia Intra corpuscular (FP)
Deprecated Cohorts: No new cohorts were added in this release.
Modified Cohorts: 0 were modified.
New Cohorts: 11 were added.
258: [P] Anaphylaxis or Anaphylactic shock events (1Pe, 0Era, 30W)
259: [P] Anaphylaxis all cause (1Pe, 0Era, 30W)
260: [P] ST elevated myocardial infarction with inpatient admission (7Pe, 180Era)
261: [P] Non ST elevated myocardial infarction with inpatient admission (7Pe, 180Era)
262: [P] Unstable Angina with inpatient admission (7Pe, 180Era)
263: [P] Unstable Angina OR NSTEMI with inpatient admission (7Pe, 180Era)
264: [P] Acute Hepatic Failure in persons with liver disease (90Pe, 180W)
265: [P] Drug Induced Acute Hepatic Failure (90Pe, 180W)
267: [P] Acute Kidney Injury AKI, in persons with chronic kidney disease (7Pe, 30W)
268: [P] Acute Kidney Injury AKI, in persons with NO chronic kidney disease (7Pe, 30W)
269: [P] Acute Kidney Injury (AKI) (7Pe, 30W)
Deprecated Cohorts: No new cohorts were added in this release.
Modified Cohorts: 3 were modified.
71: [P] Acute myocardial infarction with inpatient admission (7Pe, 180Era)
221: [P] Anaphylaxis Non Environmental exposure related (1Pe, 0Era, 30W)
234: [P] Appendicitis (1Pe, 0Era, 365W)
Accepted Cohort: 3 cohorts were accepted. cohortId 23, 24 and 25 were considered accepted to the OHDSI Phenotype Library. This cohort is deemed validated as it represents a convention and thus do not need to go through peer review process.
23: Inpatient Hospitalization (1Pe, 0Era)
24: Emergency room visits (0Pe, 0Era)
25: All cause mortality
New Cohorts: 8 were added.
100: [P] Alzheimer's disease
119: [P] Systemic lupus erythematosus (FP)
251: [P] Acute pancreatitis (7Pe, 0Era, 365W)
253: [P] Drug Induced Acute pancreatitis (7Pe, 365W)
254: [P] Drug Resistant Epilepsy
255: [P] Alzheimer's disease (based on Imfeld, 2013)
256: [P] Facial Palsy lower motor neuron including Bells Palsy (180Pe, 0Era, 183W)
257: [P] Emergency room visits or code (0Pe, 0Era)
Deprecated Cohorts: No cohorts were added in this release.
Modified Cohorts: 136 were modified. Several cohorts were changed from [P] to [W] i.e. were withdrawn from peer review consideration. Some of the cohorts in [P] pending peer review status were modified by the contributor. The changes includes cohort name changes and cohort specification changes. No accepted cohorts were modified.
2: [W] COVID-19 diagnosis or SARS-CoV-2 test (1pos) (3Ps, 7Era)
3: [P] Cough (3Ps, 30Era)
4: [P] Diarrhea (7Ps, 30Era)
5: [P] Dyspnea (14Pe, 30Era)
6: [P] Fever (3Pe, 30Era)
7: [P] Headache, Migraine or related Neurologic pain (7Pe, 30Era)
8: [P] Anosmia OR Hyposmia OR Dysgeusia (7Ps, 180Era)
9: [P] Sore throat (7Pe, 30Era)
10: [P] Nausea or Vomiting (3Pe, 30Era)
11: [P] Malaise or fatigue (3P, 30Era)
12: [P] Rhinitis or common cold (7P, 30Era)
13: [P] Myalgia (not explained by injury, ischemia or systemic inflammation) (3Pe, 30Era)
14: [P] Myalgia (3Pe, 30Era)
15: [W] Exposure to Viral Disease (7Pe, 30Era)
16: [W] Exposure to SARS-Cov 2 and coronavirus (7Pe, 30Era)
17: [W] Exposure to SARS-Cov 2 (7Pe, 30Era)
18: [P] Multiple Inflammatory Syndrome (30Pe, 30Era)
19: [P] Acute Typical Pneumonia (14Pe, 30Era)
20: [P] Bronchitis (14Pe, 90Era)
21: [P] Acute respiratory distress syndrome (ARDS) or Acute Respiratory Failure (3Pe, 30Era)
22: [W] SARS-CoV-2 testing (1Ps, 0Era)
26: [P] Asthma or Chronic obstructive pulmonary disease (COPD) (FP)
27: [P] Asthma without COPD (FP)
28: [P] Chronic obstructive pulmonary disease (COPD) without asthma (FP)
29: [W] Autoimmune condition (FP)
30: [P] Tuberculosis (FP)
31: [P] Malignant neoplasm excluding non-melanoma skin cancer (FP)
32: [P] Obesity (FP)
33: [P] Dementia (FP)
34: [P] Hypertensive disorder or hypertensive complications (FP)
35: [W] Chronic kidney disease (FP)
36: [P] Human immunodeficiency virus (not HIV2) infection (FP)
37: [P] Hepatitis C (FP)
38: [P] Heart disease (FP)
39: [W] End stage renal disease (FP)
40: [P] Diabetes Mellitus Type 2 (FP)
41: [W] Chronic kidney disease broad (FP)
42: [W] End stage renal disease broad (FP)
43: [P] Respiratory or pulmonary tuberculosis (FP)
44: [W] COVID-19 diagnosis (3Pe, 7Era)
45: [W] COVID-19 diagnosis with SARS-Cov-2 test (-3d to 3d) (3Pe, 21Era)
46: [W] COVID-19 diagnosis and SARS-CoV-2 test (1pos) within 3d (3Pe, 21Era)
47: [W] COVID-19 diagnosis and SARS-CoV-2 test (1pos) (0neg) within 3d (3Pe, 21Era)
48: [W] COVID-19 diagnosis and SARS-CoV-2 test (0pos upto 3d, 1neg within 3d) (3Pe, 7Era)
51: [W] SARS-CoV-2 test positive result (0Ps, 0Era)
52: [W] SARS-CoV-2 test negative result (0Ps, 0Era)
53: [W] SARS-CoV-2 test positive or negative result - keep persons with positive (0Ps, 0Era)
54: [P] Febrile seizure (1Pe, 0Era, 42W)
55: [W] COVID-19 diagnosis or SARS-CoV-2 test (1pos) (3Ps, 21Era)
56: [P] SARS-CoV-2 test (1pos) or COVID-19 diagnosis with (0 neg -3d to 3d) (3Ps, 21Era)
57: [P] Bleeding (1Pe, 0Era, 30W)
58: [W] SARS-CoV-2 test positive result (3Ps, 21Era)
59: [W] COVID-19 diagnosis with no SARS-CoV-2 test (3Ps, 21Era)
60: [W] SARS-CoV-2 test positive and negative result (0Ps, 0Era)
61: [P] Bradycardia or heart block with inpatient admission (1Pe, 30Era)
62: [P] Generalized Seizure (1Pe, 0Era, 42W)
63: [P] Transverse myelitis or symptoms (1Ps, 0Era, 365W)
64: [W] Flu-like symptoms fever, cough, malaise, fatigue, dyspnea, myalgia (3P, 30Era)
65: [W] Acute pancreatitis with inpatient admission (3Pe, 30Era)
66: [W] Acute renal failure with inpatient admission (3Pe, 30Era)
67: [W] Hepatic failure with inpatient admission (3Pe, 30Era)
68: [W] Heart failure with inpatient admission (3Pe, 30Era)
69: [W] Angioedema with inpatient admission (7Ps, 30Era)
70: [P] Stroke (ischemic or hemorrhagic) with inpatient admission (7Ps, 30Era)
71: [P] Acute myocardial infarction with inpatient admission (7Ps, 180Era)
72: [P] Influenza diagnosis or positive test result (7Pe, 90Era)
73: [W] Pregnancy (270P, 0Era)
74: [P] Hemorrhagic stroke (intracerebral bleeding) with inpatient admission (7Ps, 180Era)
75: [P] Ischemic stroke with inpatient admission (7Ps, 180Era)
76: [P] Transient ischemic attack with inpatient admission (7Ps, 30Era)
77: [P] Gastrointestinal bleeding with inpatient admission (7Ps, 30Era)
78: [P] Cardiac arrhythmia with inpatient admission (1Pe, 30Era)
79: [P] Dialysis with inpatient admission (1Ps, 7Era)
80: [P] Extracorporeal Membrane Oxygenation with inpatient admission (1Pe, 30Era)
81: [P] Cesarean section (7Pe, 180Era)
82: [P] Intensive services during hospitalization (1Ps, 30Era)
84: [P] SARS-CoV-2 test (1pos) or COVID-19 diagnosis with (1pos or 0 neg 0d to 3d) (3Ps, 180Era)
85: [P] SARS-CoV-2 test (1pos) or COVID-19 diagnosis with (1pos or 0 neg 0d to 3d) (3Ps, 21Era)
86: [W] SARS-CoV-2 test positive or negative result (0Ps, 0Era)
87: [W] SARS-CoV-2 test (1Ps, 0Era)
95: [P] Delirium (FP)
123: [W] First event of Suicide attempt, including injuries and poisonings with undetermined, 365 days
189: [P] Right Upper Quadrant Pain (Pe1, 0Era, 14W)
190: [P] Abdominal Distension (Pe1, 0Era, 14W)
191: [P] Fatigue, Malaise, Lethargy, Anorexia (Pe1, 0Era, 14W)
192: [P] Nausea or Vomiting (Pe1, 0Era, 7W)
193: [P] Jaundice or Itching (Pe1, 0Era, 14W)
194: [P] Encephalopathy or its presentations (Pe1, 0Era, 30W)
195: [P] Urothelial bladder cancer (FP)
197: [P] Coronary Artery Disease from vessel disease to ischemic injury (FP)
205: [W] Acute pancreatitis (7Pe, 0Era, 365W)
206: [W] Drug Induced Acute pancreatitis (7Pe, 365W)
207: [P] Acquired Pure Red Cell Aplasia
208: [P] Neutropenic Fever (3Pe, 30Era)
209: [P] Hemolytic Anemia, Extra corpuscular Acquired - G6PD deficiency excluded (7Pe, 0Era, 365W)
210: [P] Hemolytic Anemia, Extra corpuscular Acquired (7Pe, 0Era, 365W)
211: [P] Pancytopenia, Acquired
213: [P] Acquired Neutropenia or unspecified leukopenia (21Pe, 365Era)
214: [P] Acquired Isolated Neutropenia or unspecified leukopenia (21Pe, 365Era)
215: [P] Isolated Immune Thrombocytopenia (180Pe, 365Era)
216: [P] Isolated Immune Thrombocytopenia in absence of common thrombocytopenia causes (180Pe, 365Era)
217: [P] Thrombotic microangiopathy (TMA) or Microangiopathic hemolytic anemia (MAHA)
218: [P] Rhabdomyolysis (3Pe, 0Era, 180W)
219: [P] Sudden Cardiac arrest or cardiac death
220: [P] Angioedema (3Pe, 0Era, 180W)
221: [P] Anaphylaxis Non Environmental exposure related (1Pe, 0Era, 180W)
222: [P] Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum
223: [P] Posterior reversible encephalopathy syndrome PRES (FP)
224: [P] Long QT Syndrome or QT prolonged (Acquired)
225: [P] Drug-induced Lupus (180Pe, 0Era, 365W)
226: [P] Drug Rash with Eosinophilia and Systemic Symptoms DRESS (1Pe, 0Era, 365W)
227: [P] Severe Cutaneous Adverse Reaction SCAR (SJS+TEN+DRESS+EM) (3Pe, 0Era, 365W)
228: [P] Severe Cutaneous Adverse Reaction SCAR (SJS+TEN+DRESS) (3Pe, 0Era, 365W)
229: [P] Progressive multifocal leukoencephalopathy
230: [P] Autoimmune hepatitis (1Pe, 0Era, 365W)
231: [P] Erythema multiforme (3Pe, 0Era, 365W)
232: [P] Paresthesia (3Pe, 0Era, 365W)
233: [P] Hemorrhagic stroke (1Pe, 0Era, 180W)
234: [P] Appendicitis (1Pe, 0Era, 365W)
235: [P] Guillain Barre syndrome (180Pe, FP)
236: [P] Idiopathic Peripheral Neuropathy (1Pe, 0Era, 365W)
237: [P] Kawasaki disease (1Pe, 0Era, 365W)
238: [P] Optic Neuritis (7Pe, 0Era, 365W)
239: [P] Narcolepsy events (1Pe, 0Era, 365W)
240: [P] Muscle weakness or monoplegia (1Pe, 0Era, 365W)
241: [P] Urticaria (1Pe, 0Era, 30W)
243: [P] Tinnitus (1Pe, 0Era, 365W)
244: [P] Dizziness (1Pe, 0Era, 180W)
245: [P] Hepatic Thrombosis (90Pe, 0Era)
246: [P] Portal vein thrombosis (90Pe, 0Era)
247: [P] Deep Vein Thrombosis DVT (90Pe, 0Era)
248: [P] Disseminated intravascular coagulation DIC (1Pe, 0Era, 365W)
249: [P] Ischemic (Non-hemorrhagic) Stroke (1Pe, 0Era, 365W)
New Cohorts: 43 were added. 205: [P] Acute pancreatitis (7Pe, 0Era, 365W) 206: [P] Drug Induced Acute pancreatitis (7Pe, 365W) 207: [P] Acquired Pure Red Cell Aplasia 208: [P] Neutropenic Fever (3Pe, 30Era) 209: [P] Hemolytic Anemia, Extra corpuscular Acquired - G6PD deficiency excluded (7Pe, 0Era, 365W) 210: [P] Hemolytic Anemia, Extra corpuscular Acquired (7Pe, 0Era, 365W) 211: [P] Pancytopenia, Acquired 213: [P] Acquired Neutropenia or unspecified leukopenia (21Pe, 365Era) 214: [P] Acquired Isolated Neutropenia or unspecified leukopenia (21Pe, 365Era) 215: [P] Isolated Immune Thrombocytopenia (180Pe, 365Era) 216: [P] Isolated Immune Thrombocytopenia in absence of common thrombocytopenia causes (180Pe, 365Era) 217: [P] Thrombotic microangiopathy or Microangiopathic hemolytic anemia 218: [P] Rhabdomyolysis (3Pe, 0Era, 180W) 219: [P] Sudden Cardiac arrest or cardiac death 220: [P] Angioedema (3Pe, 0Era, 180W) 221: [P] Anaphylaxis Non Environmental exposure related (1Pe, 0Era, 180W) 222: [P] Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum 223: [P] Posterior reversible encephalopathy syndrome (PRES) 224: [P] Long QT Syndrome or QT prolonged (Acquired) 225: [P] Drug-induced Lupus (7Pe, 0Era, 365W) 226: [P] Drug Rash with Eosinophilia and Systemic Symptoms DRESS (1Pe, 0Era, 365W) 227: [P] Severe Cutaneous Adverse Reaction SCAR (SJS+TEN+DRESS+EM) (3Pe, 0Era, 365W) 228: [P] Severe Cutaneous Adverse Reaction SCAR (SJS+TEN+DRESS) (3Pe, 0Era, 365W) 229: [P] Progressive multifocal leukoencephalopathy 230: [P] Autoimmune hepatitis (1Pe, 0Era, 365W) 231: [P] Erythema multiforme (3Pe, 0Era, 365W) 232: [P] Paresthesia (3Pe, 0Era, 365W) 233: [P] Hemorrhagic stroke (1Pe, 0Era, 180W) 234: [P] Appendicitis (1Pe, 0Era, 365W) 235: [P] Guillain Barre syndrome (1Pe, 0Era, 365W) 236: [P] Idiopathic Peripheral Neuropathy (1Pe, 0Era, 365W) 237: [P] Kawasaki disease (1Pe, 0Era, 365W) 238: [P] Optic Neuritis (7Pe, 0Era, 365W) 239: [P] Narcolepsy events (1Pe, 0Era, 365W) 240: [P] Muscle weakness or monoplegia (1Pe, 0Era, 365W) 241: [P] Urticaria (1Pe, 0Era, 365W) 243: [P] Tinnitus (1Pe, 0Era, 365W) 244: [P] Dizziness (1Pe, 0Era, 365W) 245: [P] Hepatic Thrombosis (1Pe, 0Era, 365W) 246: [P] Portal vein thrombosis (1Pe, 0Era, 365W) 247: [P] Deep Vein Thrombosis DVT (1Pe, 0Era, 365W) 248: [P] Disseminated intravascular coagulation DIC (1Pe, 0Era, 365W) 249: [P] Ischemic (Non-hemorrhagic) Stroke (1Pe, 0Era, 365W) Deprecated Cohorts: No new cohorts were added in this release. Modified Cohorts: No cohorts were modified in this release.
New Cohorts: No new cohorts were added in this release.
Modified Cohorts: 85 were modified. These are only name modifications. These cohorts have not undergone Peer review process. They are not considered accepted. However, because of grandfathered status (i.e. these cohorts existed in Phenotype Library prior to version 3.0, results for these cohorts are computed as part of PhenotypeLibraryDiagnostics study package - unless withdrawn). The Cohort JSON specifications were not changed.
2: [P] COVID-19 diagnosis or SARS-CoV-2 test (1pos) (3Ps, 7Era)
3: [P] Cough (3Ps, 30Era)
4: [P] Diarrhea (7Ps, 30Era)
5: [P] Dyspnea (14Pe, 30Era)
6: [P] Fever (3Pe, 30Era)
7: [P]Headache, Migraine, Neurologic pain (7Pe, 30Era)
8: [P] Anosmia OR Hyposmia OR Dysgeusia (7Ps, 180Era)
9: [P] Sore throat (7Pe, 30Era)
10: [P] Nausea or Vomiting (3Pe, 30Era)
11: [P] Malaise or fatigue (3P, 30Era)
12: [P] Rhinitis or common cold (7P, 30Era)
13: [P] Myalgia (not including secondary causes) (3Pe, 30Era)
14: [P] Myalgia (3Pe, 30Era)
15: [P] Exposure to Viral Disease (7Pe, 30Era)
16: [P] Exposure to SARS-Cov 2 and coronavirus (7Pe, 30Era)
17: [P] Exposure to SARS-Cov 2 (7Pe, 30Era)
18: [P] Multiple Inflammatory Syndrome (30Pe, 30Era)
19: [P] Pneumonia (14Pe, 30Era)
20: [P] Bronchitis (14Pe, 90Era)
21: [P] Acute respiratory distress syndrome (ARDS) or Acute Respiratory Failure (3Pe, 30Era)
22: [P] SARS-CoV-2 testing (1Ps, 0Era)
23: [P] Hospitalization (1Pe, 30Era)
24: [P] Emergency room visits (0Pe, 0Era)
25: [P] All cause mortality
26: [P] Asthma or Chronic obstructive pulmonary disease (COPD) (FP)
27: [P] Asthma without COPD (FP)
28: [P] Chronic obstructive pulmonary disease (COPD) without asthma (FP)
30: [P] Tuberculosis (FP)
31: [P] Malignant neoplasm excluding non-melanoma skin cancer (FP)
32: [P] Obesity (FP)
33: [P] Dementia (FP)
34: [P] Hypertension (FP)
36: [P] Human immunodeficiency virus infection (FP)
37: [P] Hepatitis C (FP)
38: [P] Heart disease (FP)
40: [P] Diabetes Mellitus Type 2 (FP)
43: [P] Tuberculosis broad (FP)
45: [P] COVID-19 diagnosis with SARS-Cov-2 test (-3d to 3d) (3Pe, 21Era)
46: [P] COVID-19 diagnosis and SARS-CoV-2 test (1pos) within 3d (3Pe, 21Era)
47: [P] COVID-19 diagnosis and SARS-CoV-2 test (1pos) (0neg) within 3d (3Pe, 21Era)
48: [P] COVID-19 diagnosis and SARS-CoV-2 test (0pos upto 3d, 1neg within 3d) (3Pe, 7Era)
51: [P] SARS-CoV-2 test positive result (0Ps, 0Era)
52: [P] SARS-CoV-2 test negative result (0Ps, 0Era)
53: [P] SARS-CoV-2 test positive or negative result - keep persons with positive (0Ps, 0Era)
54: [P] Febrile seizure (1Ps, 0Era)
55: [P] COVID-19 diagnosis or SARS-CoV-2 test (1pos) (3Ps, 21Era)
56: [P] SARS-CoV-2 test (1pos) or COVID-19 diagnosis with (0 neg -3d to 3d) (3Ps, 21Era)
57: [P] Bleeding (1Ps, 30Era)
58: [P] SARS-CoV-2 test positive result (3Ps, 21Era)
59: [P] COVID-19 diagnosis with no SARS-CoV-2 test (3Ps, 21Era)
60: [P] SARS-CoV-2 test positive and negative result (0Ps, 0Era)
61: [P] Bradycardia or heart block with inpatient admission (1Pe, 30Era)
62: [P] Generalized Seizure (1Ps, 0Era)
63: [P] Transverse myelitis (or symptoms with transverse myelitis) 365dWO (1Ps, 0Era)
64: [P] Flu-like symptoms (3P, 30Era)
65: [P] Acute pancreatitis with inpatient admission (3Pe, 30Era)
66: [P] Acute renal failure with inpatient admission (3Pe, 30Era)
67: [P] Hepatic failure with inpatient admission (3Pe, 30Era)
68: [P] Heart failure with inpatient admission (3Pe, 30Era)
69: [P] Angioedema with inpatient admission (7Ps, 30Era)
70: [P] Stroke (ischemic or hemorrhagic) with inpatient admission (7Ps, 30Era)
71: [P] Acute myocardial infarction with inpatient admission (7Ps, 180Era)
72: [P] Influenza (narrow) (7Pe, 90Era)
74: [P] Hemorrhagic stroke (intracerebral bleeding) with inpatient admission (7Ps, 180Era)
75: [P] Ischemic stroke with inpatient admission (7Ps, 180Era)
76: [P] Transient ischemic attack with inpatient admission (7Ps, 30Era)
77: [P] Gastrointestinal bleeding with inpatient admission (7Ps, 30Era)
78: [P] Cardiac arrhythmia with inpatient admission (1Pe, 30Era)
79: [P] Dialysis with inpatient admission (1Ps, 7Era)
80: [P] Extracorporeal Membrane Oxygenation with inpatient admission (1Ps, 30Era)
81: [P] Cesarean section (7Pe, 180Era)
82: [P] Intensive services during hospitalization (1Ps, 30Era)
84: [P] SARS-CoV-2 test (1pos) or COVID-19 diagnosis with (1pos or 0 neg 0d to 3d) (3Ps, 180Era)
85: [P] SARS-CoV-2 test (1pos) or COVID-19 diagnosis with (1pos or 0 neg 0d to 3d) (3Ps, 21Era)
86: [P] SARS-CoV-2 test positive or negative result (0Ps, 0Era)
87: [P] SARS-CoV-2 test (1Ps, 0Era)
95: [P] Delirium (FP)
189: [P] Right Upper Quadrant Pain (Pe1, 3Era)
190: [P] Abdominal Distension (Pe1, 7Era)
191: [P] Fatigue, Malaise, Lethargy, Anorexia (Pe1, 1Era)
192: [P] Nausea or Vomiting (Pe1, 7Era)
193: [P] Jaundice or Itching (Pe1, 7Era)
194: [P] Encephalopathy or its presentations (Pe1, 7Era)
195: [P] Urothelial bladder cancer (FP)
197: [P] Coronary Artery Disease from vessel disease to ischemic injury (FP)
Withdrawn Cohorts: 13 were withdrawn prior to peer review. These cohorts have not undergone Peer review process. They are not considered accepted. It has been withdrawn prior to peer review. The Cohort JSON specifications were not changed. 29: [W] Autoimmune condition (FP) 35: [W] Chronic kidney disease (FP) 39: [W] End stage renal disease (FP) 41: [W] Chronic kidney disease broad (FP) 42: [W] End stage renal disease broad (FP) 44: [W] COVID-19 diagnosis (3Pe, 7Era) 73: [W] Pregnancy (270P, 0Era) 123: [W] First event of Suicide attempt, including injuries and poisonings with undetermined, 365 days 196: [W] Rheumatoid arthritis (FP) 198: [W] Crohns disease (FP) 199: [W] Major Depressive Disorder (FP) 200: [W] Plaque psoriasis (FP) 201: [W] Ulcerative colitis (FP)
Vignette: Created new vignette 'Guidelines on writing clinical description for Condition Phenotypes' by taking content out of 'Cohort Definition Submission Requirements'. Added several vignette stubs with cross reference.
Vignette updates
Vignette: Table format for Cohort Definitions in OHDSI Phenotype Library using reactable.
Added Vignette: Cohort Definition Submission Requirements.
Added Vignette: Cohort Definitions in OHDSI Phenotype Library Added new function: to get log of phenotype changes
Added Vignette: How to use Phenotype Library R Package Added tests to conform to HADES This package is now part of OHDSI HADES.
Cohorts in this release are all new. Source: atlas-phenotype.ohdsi.org
Initial version using new structure.